Azithromycin Given in Labor Cuts Maternal, Neonatal Infections

Share this content:
Azithromycin Given in Labor Cuts Maternal, Neonatal Infections
Azithromycin Given in Labor Cuts Maternal, Neonatal Infections

TUESDAY, Jan. 31, 2017 (HealthDay News) -- Administration of azithromycin during labor is associated with a reduction in maternal and neonatal clinical infections, according to a study published online Jan. 27 in Pediatrics.

Claire Oluwalana, M.D., from the Medical Research Council Unit in Banjul, the Gambia, and colleagues conducted a randomized trial involving 829 Gambian women in labor. Participants were given an oral dose of azithromycin or placebo and were followed for up to eight weeks after delivery.

Eight infants died per arm during the follow-up period. There were no reports of maternal deaths or serious adverse events related to the intervention. The researchers found that the azithromycin group had a significantly lower incidence of maternal infections (3.6 versus 9.2 percent; relative risk [RR], 0.40; 95 percent confidence interval [CI], 0.22 to 0.71; P = 0.002) and significantly lower prevalence of mastitis (1.4 versus 5.1 percent; RR, 0.29; 95 percent CI, 0.12 to 0.70; P = 0.005) and fever (1.9 versus 5.8 percent; RR, 0.33; 95 percent CI, 0.15 to 0.74; P = 0.006). In the azithromycin group, newborns had a lower overall prevalence of infections (18.1 versus 23.8 percent; RR, 0.76; 95 percent CI, 0.58 to 0.99; P = 0.052) and skin infections (3.1 versus 6.4 percent; RR, 0.49; 95 percent CI, 0.25 to 0.93; P = 0.34).

"Azithromycin given to women in labor decreases infections in both women and newborns during the puerperal period," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Recent Decline in Prescription Opioid Use Among U.S. Teens

Recent Decline in Prescription Opioid Use Among U.S. ...

Lifetime prevalence of use peaked in 1989, 2002, and remained stable until decline in 2013 to 2015

Treatment Seeking Low Among Teens With Eating Disorders

Treatment Seeking Low Among Teens With Eating Disorders

Those with counter-stereotypic presentation even less likely to seek treatment

Optical Clearing Agent Ups No. of Laser Passes in Tattoo Removal

Optical Clearing Agent Ups No. of Laser Passes ...

Findings based on number of laser passes during a five-minute tattoo removal session

is free, fast, and customized just for you!

Already a member?

Sign In Now »